Roche in neuroscience: overcoming diseases of the nervous system
Hundreds of illnesses affect the brain and its connections to the body. We are committed to using the latest science to understand how diseases of the nervous system work and to developing new ways to diagnose and treat them.
The brain makes us who we are. It allows us to think, learn, feel, connect with others and make our way in the world.
Illnesses that affect the brain and its connections to the body change who we are and what we can accomplish – interrupting careers, burdening families, cutting ties to the world and limiting dreams for the future.
These diseases are not just disabling; some can also shorten life.
A challenge for society
The toll of these diseases is staggering.
An estimated 700 million people – more than one in every 10 people – have disorders that undermine how the brain develops or functions.1
The personal and financial cost to patients, families, caregivers and society is immense.
So far, it has been tremendously challenging to develop novel medicines for people with nervous system disorders, with many failures along the way.
Advancing knowledge of the brain
Yet there is reason for hope.
Every day, a better understanding of genetics, advances in imaging technologies, and data from clinical studies are giving researchers new insights into how the brain and its connections work – and what happens when they don’t.
In fact, there’s never been a better time to be in neuroscience than right now because of this burgeoning understanding of the biology of the nervous system.
Discovering new medicines and tools
Our scientists are leading the effort to advance the frontiers of neuroscience and develop life-changing medicines and novel diagnostics for people with nervous system disorders.
We are creating new clinical tools to study the brain, and new ways to diagnose and track the progress of disease.
We’re tackling these disorders at their roots, from multiple angles.
Building on our legacy
We have a history of transforming scientific insights into breakthrough diagnostics and medicines for cancer.
We want to do the same for nervous system disorders with the greatest need, whether they affect millions of people or thousands.
Working together for a common cause
No single company or institution can do this alone.
That’s why we’re collaborating with a wide range of partners, from basic researchers who are addressing fundamental questions about how the brain works to physicians, patients, caregivers, advocacy groups and other healthcare companies who make clinical trials possible.
Exploring uncharted territory
Developing medicines for people with nervous system disorders isn’t easy.
The brain is incredibly complex and remains largely uncharted. Failures are inevitable whenever you are exploring new territory.
But every step forward, no matter how small, will make a difference.
Though the challenges are great, the rewards will be greater. We have the passion and the knowledge to develop treatments for nervous system diseases and help people live their lives to the fullest.
- 1International Federation of Pharmaceutical Manufacturers & Associations. Available at http://www.ifpma.org/wp-content/uploads/2016/01/MNDs-Innovation-1.pdf. Last accessed May 2016.